Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?

Journal article

Open access

Peer reviewed

Ian M McElree, Grant M Henning, Ryan L Steinberg, Helen Y Hougen, Sarah L Mott, Michael A O'Donnell and Vignesh T Packiam

BJU international, Vol.136(1), pp.42-44

07/2025

DOI: 10.1111/bju.16716

PMCID: PMC12134428

PMID: 40118650

Files and links (1)

url

https://doi.org/10.1111/bju.16716View

Published (Version of record) Open Access

no abstract

Chemotherapy

urinary bladder neoplasms

gemcitabine

BCG vaccine

transurethral resection of bladder

UIOWA OA Agreement

Title: Subtitle: Assessing the efficacy and safety of sequential intravesical gemcitabine and docetaxel - does time from transurethral resection of bladder tumour to induction matter?
Creators: Ian M McElree - University of Iowa
Grant M Henning - Mayo Clinic in Arizona
Ryan L Steinberg - University of Iowa
Helen Y Hougen - University of Iowa
Sarah L Mott - University of Iowa
Michael A O'Donnell - Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA
Vignesh T Packiam - Rutgers, The State University of New Jersey
Resource Type: Journal article
Publication Details: BJU international, Vol.136(1), pp.42-44
DOI: 10.1111/bju.16716
PMID: 40118650
PMCID: PMC12134428
NLM abbreviation: BJU Int
ISSN: 1464-410X
eISSN: 1464-410X
Publisher: Wiley
Grant note: The John and Carol Walter Family Foundation The NIH Cancer Center Support Grant
Language: English
Electronic publication date: 03/21/2025
Date published: 07/2025
Academic Unit: Urology
Record Identifier: 9984801616502771

6 Record Views